Pharma & Biopharma
While pharmaceutical (pharma) and biopharmaceutical (biopharma) share the common goal of improving health outcomes, the two sectors differ significantly in terms of how drugs are developed, manufactured, and marketed..read more
Alnylam’s patisiran, the first ever FDA- and European Commission-approved RNAi therapeutic
Lipid nanoparticle structure On August 10, 2018, Alnylam Pharmaceuticals (Cambridge, MA) announced the first-ever FDA approval of an RNAi (RNA…
Biohaven stock slides on withdrawal of European marketing application
The drug, being developed for a rare genetic disorder and currently under review in the U.S., is seen by some…
GeneDx to Acquire Fabric Genomics to Enable AI-Powered, Decentralized Genome Interpretation
GeneDx has announced plans to acquire Fabric Genomics, a company specializing in AI-based genomic interpretation, in a move aimed at…
Nobel Prize in Medicine for discovery of cancer immunotherapy via checkpoint inhibition
Checkpoint inhibitor therapies (NIH) On October 1, 2018, the The Nobel Assembly at the Karolinska Institute announced that it had…
The Difference Between Pharma and Biopharma and Their Use of Press Release Distribution in Marketing
The pharmaceutical (pharma) and biopharmaceutical (biopharma) industries play a crucial role in healthcare by developing drugs and therapies to treat…
Oz confirmed by Senate to lead CMS
Mehmet Oz, a physician and TV personality, takes office as HHS lays off thousands of staffers and Republicans float potential…